Literature DB >> 7070119

Prednisone-responsive hereditary motor and sensory neuropathy.

P J Dyck, C J Swanson, P A Low, J D Bartleson, E H Lambert.   

Abstract

Neurologic improvement with use of prednisone, in some cases on several occasions, was demonstrated in seven patients who had a chronic progressive polyradiculoneuropathy with nerve conduction velocity and electromyographic findings consistent with segmental demyelination and axonal degeneration and increases protein concentration in the cerebrospinal fluid. These patients seemed to have the progressive form of chronic inflammatory-demyelinating polyradiculoneuropathy and, in addition, had clinical features of hereditary motor and sensory neuropathy including pes cavus and hammer toes. On systematic examination, bony abnormalities or asymptomatic neuropathy typical of subclinical inherited neuropathy was discovered among their kin. There patients might therefore be identified as having inflammatory-demyelinating hereditary motor and sensory neuropathy. These cases may represent a chance association of chronic inflammatory-demyelinating polyradiculoneuropathy and hereditary motor and sensory neuropathy, a causally linked association of these disorders, or a prednisone-responsive inherited neuropathy only. We wish to draw attention to this treatable neuropathy and to raise the question of whether environmental factors play role in the expression of dominantly inherited mutant genes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7070119

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  27 in total

1.  Inflammatory demyelinating CNS disorder in a case of X-linked Charcot-Marie-Tooth disease: positive response to natalizumab.

Authors:  Jochen H Weishaupt; Claudia Ganser; Mathias Bähr
Journal:  J Neurol       Date:  2012-03-13       Impact factor: 4.849

2.  Epineurial microvasculitis in proximal diabetic neuropathy.

Authors:  J G Llewelyn; P K Thomas; R H King
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

Review 3.  Advances in the diagnosis, pathogenesis and treatment of CIDP.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

4.  Focal cranial nerve involvement in chronic inflammatory demyelinating polyneuropathy: clinical and MRI evidence of peripheral and central lesions.

Authors:  H M Waddy; V P Misra; R H King; P K Thomas; L Middleton; I E Ormerod
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

5.  A case of cauda equina syndrome in early-onset chronic inflammatory demyelinating polyneuropathy clinically similar to charcot-marie-tooth disease type 1.

Authors:  Seung Eun Lee; Seung Won Park; Sam Yeol Ha; Taek Kyun Nam
Journal:  J Korean Neurosurg Soc       Date:  2014-06-30

6.  The effect of prednisolone in Refsum's disease.

Authors:  H Staunton; S Murphy; P Dervan
Journal:  Ir J Med Sci       Date:  1989-02       Impact factor: 1.568

7.  Chronic inflammatory demyelinating polyneuropathy in two siblings.

Authors:  A A Gabreëls-Festen; A T Hageman; F J Gabreëls; E M Joosten; W O Renier; C M Weemaes; H J ter Laak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

Review 8.  Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.

Authors:  D Pareyson; V Scaioli; M Laurà
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

9.  Chronic inflammatory demyelinating polyneuropathy in childhood: clinical and electrophysiological features.

Authors:  A Uncini; E Parano; D J Lange; D C De Vivo; R E Lovelace
Journal:  Childs Nerv Syst       Date:  1991-08       Impact factor: 1.475

Review 10.  Role of immune cells in animal models for inherited neuropathies: facts and visions.

Authors:  Mathias Mäurer; Igor Kobsar; Martin Berghoff; Christoph D Schmid; Stefano Carenini; Rudolf Martini
Journal:  J Anat       Date:  2002-04       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.